Shri Ahimsa Naturals Ltd

Shri Ahimsa Naturals Ltd

₹ 261 -4.99%
21 Nov - close price
About

Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.[1]

Key Points

Business Profile[1]
The Company is engaged in extracting and manufacturing Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE), and Crude Caffeine, and trading in herbal extracts. It supplies food & beverages, nutraceuticals, cosmetics, and pharmaceutical industries.

  • Market Cap 609 Cr.
  • Current Price 261
  • High / Low 280 / 126
  • Stock P/E 22.8
  • Book Value 72.4
  • Dividend Yield 0.00 %
  • ROCE 24.3 %
  • ROE 18.5 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 62.9 to 96.2 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2024 Mar 2025 Sep 2025
41 55 61
27 38 43
Operating Profit 14 17 18
OPM % 34% 30% 30%
1 1 3
Interest 0 1 0
Depreciation 1 1 1
Profit before tax 13 16 20
Tax % 26% 26% 26%
10 12 15
EPS in Rs 5.09 5.23 6.22
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 TTM
104 78 96 116
54 51 65 81
Operating Profit 50 27 31 35
OPM % 48% 34% 32% 30%
2 1 2 4
Interest 1 1 1 1
Depreciation 1 1 2 2
Profit before tax 51 25 30 36
Tax % 25% 26% 26%
38 19 22 27
EPS in Rs 72.99 10.21 9.39 11.45
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 23%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 18%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 19%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 5 18 23 23
Reserves 60 66 131 146
3 14 0 0
5 5 38 10
Total Liabilities 74 103 193 179
28 40 47 47
CWIP 4 8 4 5
Investments 0 0 0 0
42 56 142 127
Total Assets 74 103 193 179

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
20 6 44
-10 -19 -4
-4 10 34
Net Cash Flow 7 -4 74

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
Debtor Days 39 53 96
Inventory Days 122 340 214
Days Payable 8 18 3
Cash Conversion Cycle 154 375 307
Working Capital Days 79 133 91
ROCE % 31% 24%

Shareholding Pattern

Numbers in percentages

Mar 2025Apr 2025Sep 2025
68.68% 68.68% 68.68%
3.04% 3.04% 1.71%
8.59% 8.59% 5.03%
19.68% 19.68% 24.58%
No. of Shareholders 2,3322,332958

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents